SEC
SlamSEC
SearchBrowseEarnings

Quince Therapeutics, Inc.

Nasdaq:QNCX
Biological Products, (No Diagnostic Substances)·SOUTH SAN FRANCISCO, CA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Summary Financials

The quince is the sole member of the genus Cydonia in the Malinae subtribe of the Rosaceae family. It is a deciduous tree that bears hard, aromatic bright golden-yellow pome fruit, similar in appearance to a pear.

Revenue
—
Adj. EBITDA
-$34.3M
FY 2024
Net Income
-$31.4M
FY 2024
EPS (Diluted)
-$0.84
FY 2024
Stock Price
$0.11
+7.4%
2026-03-11
52W Range
$0.09 – $4.55
P/E Ratio
-0.1x
Market Cap
$6.0M
Cash
$24.9M
FY 2019
Total Debt
$13.4M
FY 2024
Net Cash
$11.4M
FY 2024
Enterprise Value
-$5.4M
Debt / EBITDA
0.3x
FY 2024
EV / EBITDA
0.2x
Employees
—